Pharmaceutical Material Scientists are critical to the development and optimization of materials used in drug formulation and manufacturing. They focus on understanding the chemical and physical properties of excipients, polymers, and active pharmaceutical ingredients (APIs) to ensure drug formulations are stable, bioavailable, and effective. Their role involves selecting and designing materials that improve the solubility, stability, and controlled release of drugs, addressing challenges in the delivery of both traditional small-molecule drugs and newer biologics. By tailoring materials to specific drug delivery needs, pharmaceutical material scientists help enhance the overall therapeutic outcomes while minimizing potential side effects.
Formulation scientists, regulatory bodies, and production teams rely on pharmaceutical material scientists for their expertise throughout the drug development process—from early-stage research to large-scale manufacturing. Their contributions are essential in designing innovative drug delivery systems that target specific tissues, improve patient compliance, and ensure long-term drug efficacy. With the rise of complex treatments such as gene therapies, personalized medicines, and biologics, pharmaceutical material scientists play an increasingly important role in developing next-generation drug products. Their work ensures that new therapies are not only effective but also safe, sustainable, and cost-efficient, ultimately improving patient care and driving advancements in modern medicine. By optimizing the materials used in drug development, these specialists are at the forefront of creating novel and cutting-edge drug delivery technologies.
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Precision diagnostics: Effectiveness of innovative imaging technologies for early detection of lung cancers
Huiqin Yang, ICON Clinical Research Ltd, United Kingdom
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Design and characterization of gum arabic buccal films for protein drug delivery
Krisztian Pamlenyi, University of Szeged, Hungary